M. Borrell

Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis.

G. Vilahur, L. Badimón, O. Juan-Babot, 2018, International journal of cardiology.

High rates of long‐term progression in HIV‐1‐positive elite controllers

Felipe García, M. Plana, L. Leal, 2021, Journal of the International AIDS Society.

Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration

A. Kesselheim, I. Gich, A. Barnadas, 2020, Cancer.

Contained aortic rupture secondary to post-surgery mediastinitis due to Aspergillus fumigatus

L. Izquierdo, M. Borrell, J. N. Portero, 2006 .

The conundrum of breast cancer and microbiome - A comprehensive review of the current evidence.

P. Nuciforo, E. Zamora, C. Saura, 2022, Cancer treatment reviews.

A comprehensive and longitudinal cardiac magnetic resonance imaging study of the impact of coronary ischemia duration on myocardial damage in a highly translatable animal model

G. Vilahur, L. Badimón, L. Casaní, 2022, European journal of clinical investigation.

Aneurysmal Membranous Septum As an Exceptional Cause of Paroxysmal Atrioventricular Block.

M. Vargas-Machuca, M. Borrell, B. Cano, 2016 .

Microvasculature Recovery by Angiogenesis After Myocardial Infarction.

L. Badimón, M. Borrell, 2018, Current pharmaceutical design.

Magnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA).

C. Booth, A. Barnadas, E. Amir, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.